<DOC>
	<DOCNO>NCT00274404</DOCNO>
	<brief_summary>The hypothesis antiviral drug ( valacyclovir ) reduce amount Epstein-Barr virus ( EBV ) mouth university student infectious mononucleosis ( mono ) safe drug . Because EBV cause mono , expect reduction amount virus could result faster recovery disease .</brief_summary>
	<brief_title>Controlled Trial Valacyclovir Infectious Mononucleosis</brief_title>
	<detailed_description>University Minnesota student 18 year age old refer Boynton student health service first 7 day infectious mononucleosis eligible participate . All subject enroll allow complete study , information student truly mono due primary infection EBV determine laboratory test use result . The student assign chance ( randomize ) either receive antiviral drug valacyclovir dosage 1 gram tablet every 8 hour 14 day antiviral drug . Nine research clinic visit 180 day schedule clinical exam , history , collection mouth blood sample . The amount EBV mouth blood measure molecular virology research test call real-time TaqMan polymerase chain reaction . The severity illness evaluate use scale measure degree physical activity intensity symptom . The safety drug monitor periodically check blood cell count , assess liver kidney function among parameter . Personnel lab work analyze data know subject ' study drug assignment data collect analyzed objectively . The study remain open enrollment 20 subject laboratory-confirmed primary EBV enrol follow least 2 week . The study end subject complete schedule study visit .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Infectious Mononucleosis</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Clinical diagnosis infectious mononucleosis onset 7 day enrollment ; willingness sign informed consent Willingness provide blood oral washing sample regular interval Females must negative urine pregnancy test agree use effective contraception ( barrier hormonal ) first 30 day study assign valacyclovir Corticosteroids permit prescribed subject 's primary physisican treatment acute disease Previous history mono Pregnant breast feeding Endstage renal liver disease Immunosuppressed due underlie medical disease and/or immunomodulating medication prior enrollment Onset present illness &gt; 7 day ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>infectious mononucleosis</keyword>
	<keyword>Epstein-Barr virus</keyword>
	<keyword>valacyclovir</keyword>
	<keyword>quantitative PCR</keyword>
</DOC>